Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8931 |
High Similarity |
NPD2801 |
Approved |
0.8696 |
High Similarity |
NPD1465 |
Phase 2 |
0.8634 |
High Similarity |
NPD1934 |
Approved |
0.8554 |
High Similarity |
NPD6232 |
Discontinued |
0.8528 |
High Similarity |
NPD3817 |
Phase 2 |
0.8512 |
High Similarity |
NPD7473 |
Discontinued |
0.8481 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8476 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8476 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8466 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.843 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8375 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8353 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8343 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8343 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8343 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8304 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8256 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8242 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8198 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8165 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.815 |
Intermediate Similarity |
NPD7472 |
Approved |
0.811 |
Intermediate Similarity |
NPD3226 |
Approved |
0.8107 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8103 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8095 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8025 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8012 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7988 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7976 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7975 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7975 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7975 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7975 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7955 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7952 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.795 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7944 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7917 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.791 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7898 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7882 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.787 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7857 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7849 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7849 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7844 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7836 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7834 |
Intermediate Similarity |
NPD943 |
Approved |
0.7816 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7812 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7785 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7764 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7764 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7759 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7758 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.775 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.775 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7746 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7733 |
Intermediate Similarity |
NPD919 |
Approved |
0.7722 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7716 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7669 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7665 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7657 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7647 |
Intermediate Similarity |
NPD37 |
Approved |
0.764 |
Intermediate Similarity |
NPD3748 |
Approved |
0.764 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7625 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7616 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7616 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7616 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7593 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7584 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7582 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7568 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7566 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7561 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7561 |
Intermediate Similarity |
NPD1243 |
Approved |
0.756 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7556 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7546 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7528 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7516 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7515 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7515 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7514 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7485 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7484 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7484 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7468 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7456 |
Intermediate Similarity |
NPD920 |
Approved |
0.744 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7423 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.741 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7403 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7401 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7401 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7389 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7381 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7381 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7378 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7378 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7365 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7351 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7337 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7333 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7312 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7308 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7305 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7303 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7293 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7284 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7284 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7283 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7283 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7267 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7263 |
Intermediate Similarity |
NPD5242 |
Approved |
0.725 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7239 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7219 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7197 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7197 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7195 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7193 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.7186 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7186 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7179 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7174 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7172 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.717 |
Intermediate Similarity |
NPD2797 |
Approved |
0.717 |
Intermediate Similarity |
NPD3267 |
Approved |
0.717 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7166 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.716 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7135 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7134 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7134 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7127 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7113 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7113 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7113 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7113 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7113 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7113 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7113 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7111 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.709 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7081 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7081 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7073 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7062 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7062 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7055 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7055 |
Intermediate Similarity |
NPD411 |
Approved |
0.7051 |
Intermediate Similarity |
NPD9268 |
Approved |
0.7044 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7024 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7006 |
Intermediate Similarity |
NPD17 |
Approved |
0.7006 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7 |
Intermediate Similarity |
NPD3225 |
Approved |
0.6989 |
Remote Similarity |
NPD6385 |
Approved |
0.6989 |
Remote Similarity |
NPD6386 |
Approved |
0.6968 |
Remote Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.6965 |
Remote Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.6965 |
Remote Similarity |
NPD7874 |
Approved |
0.6964 |
Remote Similarity |
NPD5408 |
Approved |
0.6964 |
Remote Similarity |
NPD5404 |
Approved |
0.6964 |
Remote Similarity |
NPD5405 |
Approved |
0.6964 |
Remote Similarity |
NPD5406 |
Approved |
0.6961 |
Remote Similarity |
NPD8127 |
Discontinued |
0.6959 |
Remote Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.6952 |
Remote Similarity |
NPD7549 |
Discontinued |
0.6952 |
Remote Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.6951 |
Remote Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.6951 |
Remote Similarity |
NPD1296 |
Phase 2 |
0.6936 |
Remote Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.6928 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6919 |
Remote Similarity |
NPD7696 |
Phase 3 |
0.6919 |
Remote Similarity |
NPD7698 |
Approved |
0.6919 |
Remote Similarity |
NPD7697 |
Approved |
0.6914 |
Remote Similarity |
NPD2798 |
Approved |
0.6909 |
Remote Similarity |
NPD6233 |
Phase 2 |
0.6905 |
Remote Similarity |
NPD7033 |
Discontinued |
0.689 |
Remote Similarity |
NPD4625 |
Phase 3 |
0.6884 |
Remote Similarity |
NPD7870 |
Phase 2 |
0.6884 |
Remote Similarity |
NPD7871 |
Phase 2 |
0.6875 |
Remote Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.6875 |
Remote Similarity |
NPD1481 |
Phase 2 |
0.6869 |
Remote Similarity |
NPD6823 |
Phase 2 |
0.6866 |
Remote Similarity |
NPD7701 |
Phase 2 |
0.6864 |
Remote Similarity |
NPD4477 |
Approved |
0.6864 |
Remote Similarity |
NPD4476 |
Approved |
0.686 |
Remote Similarity |
NPD2354 |
Approved |
0.6856 |
Remote Similarity |
NPD6534 |
Approved |
0.6856 |
Remote Similarity |
NPD6535 |
Approved |
0.6852 |
Remote Similarity |
NPD1470 |
Approved |
0.6848
|
Remote Similarity |
NPD6798 |
Discontinued |